Rep. Kevin Hern (R-Okla.) has disclosed the sale of Nike, Inc. (NKE) common stock in a Periodic Transaction Report filed with the U.S. House of Representatives, as required under the STOCK Act. The transaction, made by Hern himself, took place on August 13, 2026, and was valued in the disclosed range of $1,001 to $15,000.
The filing notes the shares were held through the Kevin Hern Traditional IRA, a retirement account structure that frequently appears in congressional trading disclosures. Because the STOCK Act only requires reporting in broad dollar bands rather than exact figures, the precise size of the sale is not publicly known beyond that range.
A Notable Timing Overlap
What makes this disclosure worth flagging is its proximity to another sale of the same stock. Company insider Mark G. Parker also sold shares of Nike on August 14, 2026 — just one day after Hern’s transaction date, and within the same 30-day disclosure window. Parker’s transaction was reported at a $0 value, a figure that can reflect certain types of equity award dispositions or exercise-related transfers rather than a cash sale in the traditional sense.
The near-simultaneous timing of a congressional trade and a corporate insider transaction in the same security is the kind of pattern whoisbuyingnow.com tracks closely, though it is important to note that overlapping dates do not by themselves indicate coordination or any improper conduct. Members of Congress, like corporate insiders, are subject to their own separate disclosure regimes, and coincidental timing in widely held, heavily traded names like Nike is not unusual.
Hern’s transaction falls under our site’s ‘congress sale’ classification, a tag we use to group disclosed sales made by members of Congress regardless of the underlying reason, which is not stated in the filing. The STOCK Act requires such disclosures within 30 to 45 days of a transaction, making this report a matter of routine legal compliance rather than a signal of any particular investment thesis.
Readers interested in how institutional and fund-level positioning compares to individual disclosures like this one can also review our ongoing coverage of Bristol John W & Co Inc’s quarterly 13F portfolio moves, which tracks a different layer of the market’s ownership picture.
As with all congressional disclosures compiled on this site, this report reflects only the information contained in the official filing. No further detail on the rationale behind the sale, the exact number of shares involved, or the broker executing the trade was included in the disclosure.